Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process
Authors:
- 1 April 2016
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 503 (1-2) , 8-15
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute
- Ministry of Health & Welfare (HI14C1771)
- Technological innovation R&D program (SA113949)
- Small and Medium Business Administration (NRF-2014R1A2A2A01005059)
This publication has 20 references indexed in Scilit:
- Development of Risperidone PLGA MicrospheresJournal of Drug Delivery, 2014
- In Vitro–In Vivo Correlations of Scalable PLGA-Risperidone Implants for the Treatment of SchizophreniaPharmaceutical Research, 2010
- Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticlesInternational Journal of Pharmaceutics, 2006
- How porosity and size affect the drug release mechanisms from PLGA-based microparticlesInternational Journal of Pharmaceutics, 2006
- Intestinal uptake and biodistribution of novel polymeric micelles after oral administrationJournal of Controlled Release, 2006
- Clinical review of a long-acting, injectable formulation of risperidoneClinical Therapeutics, 2004
- Preparation and comprehensive characterization of a calcium hydroxyapatite reference materialJournal of Research of the National Institute of Standards and Technology, 2004
- The effects of molecular weight and porosity on the degradation and drug release from polyglycolideInternational Journal of Pharmaceutics, 2004
- Pharmacokinetics and tolerability of long-acting risperidone in schizophreniaSchizophrenia Research, 2004
- The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation methodJournal of Controlled Release, 1995